| BO162776 |
22556-62-3 |
1-Oleoyl lysophosphatidic acid sodium salt- Bio-X |
|
Endogenous agonist of lysophospholipid receptors (LPA1 and LPA2) |
|
| MT16862 |
84376-63-6 |
11-delta9-Tetrahydro cannabinol-9-carboxylic acid b-D-glucuronide |
|
|
|
| NC30706 |
163042-96-4 |
2-Cl-IB-MECA |
|
Agonist of A3 adenosine receptor; antineoplastic |
|
| FA162449 |
74885-09-9 |
5-Carboxamidotryptamine |
|
|
|
| FM160701 |
1019-45-0 |
5-Methoxy-N,N-dimethyltryptamine |
|
|
|
| BM165560 |
2427-79-4 |
5-Methoxy-N,N-dimethyltryptamine hydrochloride |
|
|
|
| BF166977 |
1364933-62-9 |
5F-AB 001 |
|
Synthetic cannabinoid analog |
|
| BO166474 |
78950-78-4 |
8-OH-DPAT |
|
Serotonin (5-HT1A) receptor agonist |
|
| FM32987 |
895155-26-7 |
A-796260 |
|
|
|
| BM166976 |
895155-25-6 |
AB 005 |
|
Synthetic cannabinoid |
|
| FM61417 |
22972-55-0 |
Abn-CBD |
|
GPR55 agonist |
|
| FA16904 |
447407-36-5 |
AC 42 |
|
Muscarinic (M1) receptor agonist |
|
| BA17966 |
220556-69-4 |
ACEA |
|
Cannabinoid (CB1) receptor agonist |
|
| BA166874 |
51037-30-0 |
Acipimox |
|
Niacin receptor 1 (NIACR1) antagonist; lipid lowering |
BIO-R |
| FA31012 |
320345-99-1 |
Aclidinium bromide |
|
Muscarinic antagonist; bronchodilator |
|
| BA17967 |
229021-64-1 |
ACPA |
|
CB1 cannabinoid receptor agonist |
|
| FA103122 |
851881-60-2 |
ADX 47273 |
|
Positive allosteric modulator of mGlu5 receptors |
|
| BA167079 |
138112-76-2 |
Agomelatine- Bio-X |
|
Melatonin agonist; 5-HT2B and 5-HT2C serotonin receptor antagonist |
|
| BA164142 |
79561-22-1 |
Alarelin Acetate- Bio-X |
|
Gonadotropin-releasing hormone agonist |
|
| BA164143 |
18559-94-9 |
Albuterol |
|
β2-adrenergic receptor agonist; bronchodilator |
BIO-R |
| BA164388 |
51022-70-9 |
Albuterol sulfate- Bio-X |
|
β-adrenergic receptor agonists |
|
| BA164145 |
81403-80-7 |
Alfuzosin- Bio-X |
|
α-adrenoceptor antagonist; treatment for benign prostatic hyperplasia |
|
| FA150825 |
59338-87-3 |
Alizapride hydrochloride |
|
Dopamine (D2) receptor antagonist |
|
| BA166116 |
913358-93-7 |
Almorexant hydrochloride |
|
Antagonist of orexin receptors OX1 and OX2 |
|
| FA17315 |
154323-46-3 |
Almotriptan hydrochloride |
|
Serotonin (5-HT) receptor agonist |
|
| BA166465 |
122852-69-1 |
Alosetron hydrochloride- Bio-X |
|
Serotonin 5-HT3 receptor antagonist |
|
| FA31828 |
745-65-3 |
Alprostadil |
|
Inhibits platelet aggregation; vasodilator |
|
| BA164152 |
156053-89-3 |
Alvimopan |
|
Peripheral μ-opioid receptor antagonist; gastroprokinetic |
|
| BA17338 |
183232-66-8 |
AM 251 NEW |
|
CB1 cannabinoid receptor antagonist |
|
| BA164153 |
177036-94-1 |
Ambrisentan- Bio-X |
|
Endothelin A receptor antagonist; anti-hypertensive |
|
| FA148913 |
155148-31-5 |
AMD 3100 octahydrochloride |
|
Chemokine receptor CXCR4 antagonist |
|
| FA104030 |
473719-41-4 |
AMG 487 |
|
CXCR3 antagonist |
|
| BA164158 |
71675-85-9 |
Amisulpride- Bio-X |
|
Dopamine D2/D3 receptor antagonist; anti-psychotic; |
|
| BA164170 |
14028-44-5 |
Amoxapine |
|
Serotonin (5-HT2) receptor antagonist; inhibits norepinephrine reuptake |
BIO-R |
| BA166586 |
94421-68-8 |
Anandamide |
|
Endogenous cannabinoid and TRPV1 receptor agonist |
|
| FA17951 |
105219-56-5 |
Apafant |
|
Platelet-activating factor antagonist |
|
| BA165146 |
1268881-20-4 |
APD 371 NEW |
|
Cannabinoid receptor CB2 agonist; analgesic |
|
| BA166505 |
461443-59-4 |
Aplaviroc |
|
Inhibits chemokine receptor CCR5; anti-viral activity against HIV |
|
| BA164186 |
73218-79-8 |
Apraclonidine hydrochloride |
|
α2-adrenoceptor agonist; anti-glaucoma agent |
|
| BA164216 |
170729-80-3 |
Aprepitant- Bio-X |
|
Antagonist of neurokinin-1 receptor; anti-emetic |
|
| BA165448 |
733750-99-7 |
AR 231453 |
|
A potent and selective small molecule agonist of GPR119 |
|
| BA171831 |
200815-49-2 |
Arformoterol tartrate |
|
Bronchodilator |
|
| BA164218 |
129722-12-9 |
Aripiprazole- Bio-X |
|
Partial agonist of dopamine (D2) and serotonin (5-HT1A) receptors |
|
| BA45604 |
128007-31-8 |
Arvanil |
|
CB1 cannabinoid receptor and vanilloid TRPV1 (VR1) agonist |
|
| FA17998 |
65576-45-6 |
Asenapine |
|
Inhibits dopamine, serotonin and adrenergic receptors |
|
| BA167271 |
1282549-08-9 |
ASP 6432 |
|
Type 1 lysophosphatidic acid (LPA) receptor antagonist |
|
| FA18002 |
68844-77-9 |
Astemizole |
|
Histamine-1 receptor antagonist; hERG K+ channel blocker |
|
| BA166036 |
29122-68-7 |
Atenolol |
|
β-adrenoceptor blocker |
BIO-R |
| FA64946 |
104075-48-1 |
Atipamezole hydrochloride |
|
α2-adrenoceptor antagonist |
|
| FA40914 |
914453-95-5 |
Atosiban acetate |
|
Oxytocin receptor antagonist |
|